School of Biosciences

Join us in our journey of discovery


profile image for Professor Mark Smales

Professor Mark Smales

Professor of Industrial Biotechnology

School of Biosciences


Professor Mark Smales is currently Professor of Industrial Biotechnology in the School of Biosciences at the University of Kent. The group headed by Mark has a number of on-going projects whose objectives are to further advance our understanding of biotechnological products and processes at the fundamental biological or chemical level to enable their manipulation and control for improved biotherapeutic recombinant protein yields and quality. His group in particular focusses upon the investigation of cultured mammalian cells for the purposes of producing biotherapeutic proteins for the treatment of disease and for the generation of diagnostics. This includes upstream and downstream bioprocessing and embracing and utilising novel technologies such as genome editing to engineering cell systems and tune them for the desired use.

Mark is Director of the Industrial Biotechnology Centre and a member of the Industrial Biotechnology and Synthetic Biology Research Group.

ORCID ID: 0000-0002-2762-4724

back to top


Also view these in the Kent Academic Repository

Tamošaitis, L. and Smales, M. (2018). Meta-analysis of publicly available Chinese hamster ovary (CHO) cell transcriptomic datasets for identifying engineering targets to enhance recombinant protein yields. Biotechnology Journal [Online] 13:1800066. Available at:
Vito, D. and Smales, C. (2018). The Long Non-Coding RNA Transcriptome Landscape in CHO Cells Under Batch and Fed-Batch Conditions. Biotechnology Journal [Online] 13:1800122. Available at:
Gourbatsi, E., Povey, J. and Smales, C. (2018). The effect of formulation variables on protein stability and integrity of a model IgG4 monoclonal antibody and translation to formulation of a model ScFv. Biotechnology Letters [Online] 40:33-46. Available at:
Jossé, L., Zhang, L. and Smales, C. (2018). Application of microRNA Targeted 3′UTRs to Repress DHFR Selection Marker Expression for Development of Recombinant Antibody Expressing CHO Cell Pools. Biotechnology Journal [Online] 13:1800129. Available at:
Bastide, A. et al. (2017). RTN3 Is a Novel Cold-Induced Protein and Mediates Neuroprotective Effects of RBM3. Current Biology [Online] 27:638-650. Available at:
Godfrey, C. et al. (2017). Polysome Profiling of mAb Producing CHO Cell Lines Links Translational Control of Cell Proliferation and Recombinant mRNA Loading onto Ribosomes with Global and Recombinant Protein Synthesis. Biotechnology Journal [Online] 12:1700177. Available at:
Almeida, A. et al. (2017). Investigations into, and development of, a lyophilized and formulated recombinant human factor IX produced from CHO cells. Biotechnology Letters [Online] 39:1109-1120. Available at:
Migani, D., Smales, C. and Bracewell, D. (2017). Effects of lysosomal biotherapeutic recombinant protein expression on cell stress and protease and general host cell protein (HCP) release in Chinese hamster ovary cells. Biotechnology Progress [Online] 33:666-676. Available at:
Saintas, E. et al. (2017). Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-AS. PLoS ONE [Online] 12:e0172140. Available at:
Vasilev, N. et al. (2016). Developments in the production of mucosal antibodies in plants. Biotechnology Advances [Online] 34:77-87. Available at:
Gourbatsi, E. et al. (2016). Biotherapeutic protein formulation variables influence protein integrity and can promote post-translational modifications as shown using chicken egg white lysozyme as a model system. Biotechnology Letters [Online] 38:589-596. Available at:
Josse, L. et al. (2016). mTORC1 signalling and eIF4E/4E-BP1 translation initiation factor stoichiometry influence recombinant protein productivity from GS-CHOK1 cells. Biochemical Journal [Online] 473:4651-4664. Available at:
Knight, J. et al. (2016). Cooling-induced SUMOylation of EXOSC10 down-regulates ribosome biogenesis. RNA [Online] 22:623-635. Available at:
Williams, M. et al. (2016). Microwave-assisted synthesis of highly crystalline, multifunctional iron oxide nanocomposites for imaging applications. RSC Advances [Online] 6:83520-83528. Available at:
Feary, M. et al. (2016). Methionine sulfoximine supplementation enhances productivity in GS-CHOK1SV cell lines through glutathione biosynthesis. Biotechnology Progress [Online] 33:17-25. Available at:
Lintern, K. et al. (2016). Residual on column host cell protein analysis during lifetime studies of protein A chromatography. Journal of Chromatography A [Online] 1461:70-77. Available at:
Chiverton, L. et al. (2016). Quantitative definition and monitoring of the host cell protein proteome using iTRAQ: a study of an industrial mAb producing CHO-S cell line. Biotechnology Journal [Online] 11:1014-1024. Available at:
Mead, E. et al. (2015). Biological Insights into the Expression of Translation Initiation Factors from Recombinant CHOK1SV Cell Lines and their Relationship to Enhanced Productivity. Biochemical Journal [Online] 472:261-273. Available at:
Bracewell, D., Francis, R. and Smales, C. (2015). The future of host cell protein (HCP) identification during process development and manufacturing linked to a risk-based management for their control. Biotechnology and Bioengineering [Online] 112:1727-1737. Available at:
Tunjung, W. et al. (2015). Anti-Cancer Effect of Kaffir Lime (Citrus Hystrix DC) Leaf Extract in Cervical Cancer and Neuroblastoma Cell Lines. Procedia Chemistry [Online] 14:465-468. Available at:
Roobol, A. et al. (2015). p58(IPK) is an Inhibitor of the eIF2α Kinase GCN2 and its Localisation and Expression Underpin Protein Synthesis and ER Processing Capacity. Biochemical Journal [Online] 465:213-225. Available at:
Hogwood, C. et al. (2015). An ultra scale-down approach identifies host cell protein differences across a panel of mAb producing CHO cell line variants. Biotechnology Journal [Online] 11:415-424. Available at:
Knight, J. et al. (2015). Eukaryotic elongation factor 2 kinase regulates the cold stress response by slowing translation elongation. Biochemical Journal [Online] 465:227-238. Available at:
Jardim, A. et al. (2015). Expression of Trypanosoma brucei gambiense Antigens in Leishmania tarentolae. Potential for Use in Rapid Serodiagnostic Tests (RDTs). PLOS Neglected Tropical Diseases [Online] 9. Available at:
Povey, J. et al. (2014). Rapid high-throughput characterisation, classification and selection of recombinant mammalian cell line phenotypes using intact cell MALDI-ToF mass spectrometry fingerprinting and PLS-DA modelling. Journal of Biotechnology [Online] 184:84-93. Available at:
Ashton, L. et al. (2014). UV resonance Raman spectroscopy: a process analytical tool for host cell DNA and RNA dynamics in mammalian cell lines. Journal of Chemical Technology and Biotechnology [Online] 90:237-243. Available at:
Masterton, R. and Smales, C. (2014). The impact of process temperature on mammalian cell lines and the implications for the production of recombinant proteins in CHO cells. Pharmaceutical Bioprocessing [Online] 2:49-61. Available at:
Hogwood, C., Bracewell, D. and Smales, C. (2014). Measurement and control of host cell proteins (HCPs) in CHO cell bioprocesses. Current Opinion in Biotechnology [Online] 30:153-160. Available at:
Roobol, A. et al. (2014). The chaperonin CCT interacts with and mediates the correct folding and activity of three subunits of translation initiation factor eIF3: b, i and h. Biochemical Journal [Online] 458:213-224. Available at:
Mead, E. et al. (2014). Control and regulation of mRNA translation. Biochemical Society transactions [Online] 42:151-154. Available at:
Hogwood, C. et al. (2013). The dynamics of the CHO host cell protein profile during clarification and protein A capture in a platform antibody purification process. Biotechnology and Bioengineering [Online] 110:240-251. Available at:
Wagstaff, J. et al. (2013). 1H NMR Spectroscopy Profiling of Metabolic Reprogramming of Chinese Hamster Ovary Cells upon a Temperature Shift during Culture. PLoS ONE 8:e77195-e77195.
Hogwood, C., Bracewell, D. and Smales, C. (2013). Host cell protein dynamics in recombinant CHO cells. Bioengineered [Online] 4:288-291. Available at:
Al-Fageeh, M. and Smales, C. (2013). Alternative Promoters Regulate Cold Inducible RNA-Binding (CIRP) Gene Expression and Enhance Transgene Expression in Mammalian Cells. Molecular Biotechnology [Online] 54:238-249. Available at:
Bracewell, D. and Smales, C. (2013). The challenges of product- and process-related impurities to an evolving biopharmaceutical industry. Bioanalysis [Online] 5:123-126. Available at:
Mead, E. et al. (2012). Experimental and In Silico Modelling Analyses of the Gene Expression Pathway for Recombinant Antibody and By-Product Production in NS0 Cell Lines. PLoS ONE [Online] 7:e47422. Available at:
Peters, S. et al. (2012). Engineering an Improved IgG4 Molecule with Reduced Disulfide Bond Heterogeneity and Increased Fab Domain Thermal Stability. Journal of Biological Chemistry [Online] 287:24525-24533. Available at:
Roobol, A. et al. (2011). ATR (ataxia telangiectasia mutated- and Rad3-related kinase) is activated by mild hypothermia in mammalian cells and subsequently activates p53. Biochemical Journal [Online] 435:499-508. Available at:
Hayes, N. et al. (2011). Modulation of Phosducin-Like Protein 3 (PhLP3) Levels Promotes Cytoskeletal Remodelling in a MAPK and RhoA-Dependent Manner. PLoS ONE [Online] 6:e28271. Available at:
Tait, A. et al. (2011). Host cell protein dynamics in the supernatant of a mAb producing CHO cell line. Biotechnology and Bioengineering [Online] 109:971-982. Available at:
Kotov, N. et al. (2011). Computational modelling elucidates the mechanism of ciliary regulation in health and disease. BMC Systems Biology [Online] 5:143. Available at:
Reid, C. et al. (2010). Rapid whole monoclonal antibody analysis by mass spectrometry: An Ultra scale-down study of the effect of harvesting by centrifugation on the post-translational modification profile. Biotechnology and Bioengineering [Online] 107:85-95. Available at:
Jossé, L., Smales, C. and Tuite, M. (2010). Transient expression of human TorsinA enhances secretion of two functionally distinct proteins in cultured Chinese hamster ovary (CHO) cells. Biotechnology and Bioengineering [Online] 105:556-566. Available at:
Masterton, R. et al. (2010). Post-translational events of a model reporter protein proceed with higher fidelity and accuracy upon mild hypothermic culturing of Chinese hamster ovary cells. Biotechnology and Bioengineering [Online] 105:215-220. Available at:
Hayes, N., Smales, C. and Klappa, P. (2009). Protein disulfide isomerase does not control recombinant IgG4 productivity in mammalian cell lines. Biotechnology and Bioengineering [Online] 105:770-779. Available at:
Al-Fageeh, M. and Smales, C. (2009). Cold-inducible RNA binding protein (CIRP) expression is modulated by alternative mRNAs. RNA [Online] 15:1164-1176. Available at:
Roobol, A. et al. (2009). Biochemical insights into the mechanisms central to the response of mammalian cells to cold stress and subsequent rewarming. FEBS Journal [Online] 276:286-302. Available at:
Povey, J. et al. (2009). Investigating variables and mechanisms that influence protein integrity in low water content amorphous carbohydrate matrices. Biotechnology Progress [Online] 25:1217-27. Available at:
Mead, E. et al. (2009). Identification of the limitations on recombinant gene expression in CHO cell lines with varying luciferase production rates. Biotechnology and Bioengineering [Online] 102:1593-1602. Available at:
Smales, C. (2008). Proceedings from the 8th PEACe Conference on Protein Expression in Animal Cells, Angra Dos Reis, Brazil, September 16-20, 2007. Molecular Biotechnology [Online] 39:87-87. Available at:
Marchant, R. et al. (2008). Metabolic rates, growth phase, and mRNA levels influence cell-specific antibody production levels from in vitro-cultured mammalian cells at sub-physiological temperatures. Molecular Biotechnology [Online] 39:69-77. Available at:
Povey, J. et al. (2008). The effect of peptide glycation on protein secondary structure. Journal of Structural Biology [Online] 161:151-161. Available at:
Parsons, J. et al. (2008). Biochemical and Structural Insights into Bacterial Organelle Form and Biogenesis. Journal of Biological Chemistry [Online] 283:14366-14375. Available at:
Underhill, M. and Smales, C. (2007). The cold-shock response in mammalian cells: investigating the HeLa cell cold-shock proteome. Cytotechnology [Online] 53:47-53. Available at:
Underhill, M. et al. (2007). Transient Gene Expression Levels from Multigene Expression Vectors. Biotechnology Progress [Online] 23:435-443. Available at:
Povey, J. et al. (2007). Comparison of the effects of 2,2,2-trifluoroethanol on peptide and protein structure and function. Journal of Structural Biology [Online] 157:329-338. Available at:
Ahmad, N. et al. (2006). On the statistical analysis of the GS-NS0 cell proteome: Imputation, clustering and variability testing. Biochimica Et Biophysica Acta-Proteins and Proteomics [Online] 1764:1179-1187. Available at:
Al-Fageeh, M. and Smales, C. (2006). Control and regulation of the cellular responses to cold shock: the responses in yeast and mammalian systems. Biochemical Journal [Online] 397:247-259. Available at:
Gourbatsi, E. et al. (2006). Noncovalently linked nuclear localization peptides for enhanced calcium phosphate transfection. Molecular Biotechnology [Online] 33:1-11. Available at:
Dinnis, D. et al. (2006). Functional proteomic analysis of GS-NS0 murine myeloma cell lines with varying recombinant monoclonal antibody production rate. Biotechnology and Bioengineering [Online] 94:830-841. Available at:
Weeks, M. et al. (2006). Monitoring changes in nisin susceptibility of Listeria monocytogenes Scott A as an indicator of growth phase using FACS. Journal of Microbiological Methods [Online] 66:43-55. Available at:
Underhill, M. et al. (2006). On the effect of transient expression of mutated eIF2 alpha and eIF4E eukaryotic translation initiation factors on reporter gene expression in mammalian cells upon cold-shock. Molecular Biotechnology [Online] 34:141-149. Available at:
Al-Fageeh, M. et al. (2006). The cold-shock response in cultured mammalian cells: Harnessing the response for the improvement of recombinant protein production. Biotechnology and Bioengineering [Online] 93:829-835. Available at:
Underhill, M. et al. (2005). eIF2 alpha phosphorylation, stress perception, and the shutdown of global protein synthesis in cultured CHO cells. Biotechnology and Bioengineering [Online] 89:805-814. Available at:
Howard, M. and Smales, C. (2005). NMR analysis of synthetic human serum albumin alpha-helix 28 identifies structural distortion upon amadori modification. Journal of Biological Chemistry 280:22582-22589.
Alete, D. et al. (2005). Proteomic analysis of enriched microsomal fractions from GS-NS0 murine myeloma cells with varying secreted recombinant monoclonal antibody productivities. Proteomics [Online] 5:4689-4704. Available at:
Weeks, M. et al. (2004). Global changes in gene expression observed at the transition from growth to stationary phase in Listeria monocytogenes ScottA batch culture. Proteomics [Online] 4:123-135. Available at:
Smales, C. et al. (2004). Comparative proteomic analysis of GS-NSO murine myeloma cell lines with varying recombinant monoclonal antibody production rate. Biotechnology and Bioengineering [Online] 88:474-488. Available at:
Smales, C. and Blackwell, L. (2003). Lysozyme conjugate immune complex formation and the effects on substrate hydrolysis. Biochemical and Biophysical Research Communications 304:818-824.
Cooke, D. et al. (2003). Use of defined estrone glucuronide-hen egg white lysozyme conjugates as signal generators in homogeneous enzyme immunoassays for urinary estrone glucuronide. Journal of Immunoassay & Immunochemistry 24:147-172.
Smales, C. et al. (2003). Evaluation of individual protein errors in silver-stained two-dimensional gels. Biochemical and Biophysical Research Communications [Online] 306:1050-1055. Available at:
Smales, C. and Blackwell, L. (2002). Purification and characterization of lysozyme-pregnanediol glucuronide conjugates: the effect of the hapten and coupling reagent on the substitution level, sites of acylation and the consequences for the development of future immunoassays. Biotechnology and Applied Biochemistry 36:101-110.
Smales, C., Pepper, D. and James, D. (2002). Protein modification during anti-viral heat-treatment bioprocessing of factor VIII concentrates, factor IX concentrates, and model proteins in the presence of sucrose. Biotechnology and Bioengineering [Online] 77:37-48. Available at:
Smales, C., Pepper, D. and James, D. (2001). Protein Modifications during Antiviral Heat Bioprocessing and Subsequent Storage. Biotechnology Progress 17:974-978.
Smales, C., Pepper, D. and James, D. (2001). Evaluation of Protein Modification during Anti-Viral Heat Bioprocessing by Electrospray Ionization Mass Spectrometry. Rapid Communications in Mass Spectrometry [Online] 15:351-356. Available at:
Davis, P., Smales, C. and James, D. (2001). How can Thermal Processing Modify the Antigenicity of Proteins? Allergy [Online] 56:56-60. Available at:
Smales, C., Pepper, D. and James, D. (2000). Protein modification during antiviral heat bioprocessing. Biotechnology and Bioengineering [Online] 67:177-188. Available at:<177::AID-BIT7>3.0.CO;2-3.
Smales, C., Pepper, D. and James, D. (2000). Mechanisms of protein modification during model anti-viral heat-treatment bioprocessing of beta-lactoglobulin variant A in the presence of sucrose. Biotechnology and Applied Biochemistry [Online] 32:109-119. Available at:
Book section
Jossé, L., Smales, C. and Tuite, M. (2012). Engineering the Chaperone Network of CHO Cells for Optimal Recombinant Protein Production and Authenticity. in: Recombinant Gene Expression. Springer New York, pp. 595-608. Available at:
Mead, E. and Smales, C. (2011). mRNA Translation and Recombinant Gene Expression from Mammalian Cell Expression Systems. in: Comprehensive Biotechnology. Elsevier, pp. 403-409. Available at:
Scott, S. et al. (2006). The molecular response(s) during cellular adaptation to, and recovery from, sub-physiological temperatures. in: Al-Rubeai, M. and Fussenegger, M. M. eds. Systems Biology. Netherlands: Springer, pp. 185-212.
Alete, D. et al. (2005). The functional competence of animal cells: Analysis of the secretory pathway. in: Godia, F. and Fussenegger, M. M. eds. Animal Cell Technology Meets Genomics. Dordrecht: Springer, pp. 71-74.
Edited book
Smales, C., Marchant, R. and Underhill, M. (2005). Characterization of therapeutic proteins by membrane and in-gel tryptic digestion. [Online]. Smales, C. M. and James, D. C. eds. Humana Press. Available at:
Showing 83 of 88 total publications in KAR. [See all in KAR]


back to top


Adherent CHO Cell Stained for Actin. CHO cells are the mammalian cell industrial workhorse.

Cell engineering and therapeutic recombinant protein biotechnology

The focus of the research in the laboratory is to work on aspects relating to improving our understanding of the biology that underpins bioprocessing and recombinant protein production from cell expression systems, particularly in vitro cultured mammalian expression systems. The laboratory is recognised internationally for its work using cultured mammalian cells for in vitro research purposes, particularly in relation to investigating the cellular constraints on recombinant protein productivity. The laboratory has extensive experience in proteome analysis and gene expression in mammalian cell systems, specifically recombinant gene expression, and is ideally placed with strong biotechnological and industrial links to exploit this technology. Currently the laboratory is funded via a number of BBSRC, EPSRC and industrial (particularly with Lonza Biologics plc) research grants and studentships, with research focussing upon investigating the molecular responses in mammalian cells upon cold-shock, the post-transcription limitations upon recombinant protein production in mammalian cells, the role of mRNA translation and its control in determining recombinant protein yields at physiological and sub-physiological temperatures, investigation of the unfolded protein response to identify novel targets for manipulation of mammalian cells in order to enhance recombinant protein production, and the investigation of protein stability with regard to formulation and delivery of biotherapeutic proteins. The work is primarily focussed upon determining the biological mechanisms that underpin each of these areas, but we are also actively involved in applying this knowledge to develop new and improved systems and processes for the biotechnology industry. Below is a sample of some of the areas we are currently interested in investigating but this is by no means inclusive. We are always interested in discussing potential projects and collaborations with academic and industrial colleagues. If you are interested, or wish to discuss graduate opportunities (Masters and PhD) or vacancies within the laboratory, please contact us.

Current Projects:

Chemical and structural integrity of proteins in the glassy state – Protein formulation and stability



A model peptide that shows how chemical modification (lower image) can  result in conformation change

This work is undertaken in collaboration with Dr Mark Howard from the School of Biosciences and Dr Roger Parker from the Institute of Food Research

There is an industrial requirement to preserve proteins prior to their use in order to maintain biological authenticity. In vitro, further degradations compromise solution state stability including hydrolysis which is generally observed at sequences containing aspartic acid (Asp-Pro is particularly susceptible), diketopiperazine formation when glycine is in the third position from the N-terminus and disulphide cross-linking reactions. As a result of the susceptibility of proteins and peptides to chemical modification, various strategies have been developed for their in vitro preservation in order to prevent such modifications. One strategy proposes that preservation will be achieved by putting the protein in the glassy state. The aim of this programme of work is to determine the physical and chemical basis and mechanisms of globular protein stability in the glassy state. There are two industrially relevant strategies for achieving stability using glass states, first; a general minimisation of molecular mobility and, second; by additionally using specific interactions in polyelectrolyte complexes. Here we are applying the following key methodologies:

  • The determination of chemical and structural modifications to peptides during glassy state stabilisation and storage.
  • Characterisation of glass transition temperatures and structural relaxation rates in proteins, peptides and their mixtures with stabilising additives.
  • Measurement of local and global mobility in proteins and protein matrix glasses using EPR spin labels and probes.
  • NMR structural analysis of the modifications to model peptides and proteins.
  • Determine the conditions under which macromolecular complexation proceeds and characterise its consequent effect on probe mobility and chemical stability.

These methodologies will allow us to acquire: (1) a comprehensive view of the chemistry and structural changes occurring in proteins during glassy state stabilisation, and (2) a physico-chemical understanding of those factors controlling stabilisation. It is anticipated that information arising from this project will enable: (a) the development of improved methodologies for the preservation of foodstuffs and therapeutic proteins, (b) establish a database of potential modifications to proteins under industrially relevant processing conditions, and (c) develop monitoring systems to detect trace amounts of modified proteins.

Individual objectives suitable for assessing the outcome of the work are:

  1. Identification of stabilising treatments, additives and product formulations that result in protein stabilisation/destabilisation and modification.
  2. Structural characterisation of protein modifications.
  3. Identification of matrices for minimising general and localised probe mobility.
  4. Formulation of an overall physico-chemical model relating chemical and physical stability of proteins in the glassy state.

We are also interested in developing high concentration monoclonal antibody liquid form


Cold stress response in in vitro cultured mammalian cells and its application for the enhancement of recombinant protein yields

Many living organisms have adapted sophisticated strategies to allow their survival over a dynamic range of temperatures. The response to elevated temperatures has been extensively studied in both prokaryotic and eukaryotic systems and generally involves the induction of heat-shock proteins (HSPs), a family of proteins that are highly conserved between all organisms from bacteria to mammals. In contrast to the HSP response, the mechanisms involved in the response to sub-physiological temperatures are poorly understood and have been studied in few organisms. A number of plant genes are induced by low temperature stress, and in prokaryotes cold stress induces several well-characterised cold-shock proteins (CSPs).

By contrast, the response of eukaryotic cells to cold-shock and the biological mechanisms that govern cellular response to sub-physiological temperatures are not well understood. Cold-stress exposures cells to two major stresses; those relating to changes in temperature and those related to changes in oxygen concentration due to higher dissolved oxygen concentrations at reduced temperatures. Although our understanding of the cold-shock response in eukaryotes is limited, several studies have demonstrated that induced CSPs are key determinants in the adaptation to growth and survival at lower temperatures although little is known about what effect changes in dissolved oxygen concentrations may play in these responses. What is becoming clear is that exposing eukaryotic cells to sub-optimal temperatures invokes a coordinated response involving modulation of the cell cycle, metabolism, transcription, translation, and the cell cytoskeleton. Moreover, the response of eukaryotes to cold stress has been implicated in adaptive thermogenesis, cold tolerance, storage of tissue, organs and cells, therapeutic treatment of brain damage, and as a method to improve recombinant protein production in mammalian cells.

We have a number of projects whose focus is to identify proteins and mechanisms involved in the molecular response(s) governing cellular adaptation to sub-physiological temperatures (37ºC, cold stress) and is pertinent to understanding how these responses are coordinated. We are also interested in the response of mammalian cells upon recovery from cold-shock. These projects investigate a number of areas of the cold stress response from the global responses as determined by global proteome approaches, and more specific investigations studying how cold stress effects the cell cytoskeleton, both in collaboration with Dr Martin Carden, to structural dynamic studies of the cold shock inducible protein CIRP and its binding to RNA ligands with Dr Richard Williamson. We are also interested in how recombinant protein production can be enhanced at lower culture temperatures and the mechanisms responsible for this and the relationship to mRNA stability and mRNA translation.


Our proposed mechanism outlining the major responses initiated upon cold stress perception in mammalian cells



























Determination of the post-transcriptional constraints that limit recombinant protein yield during bioprocessing from in vitro cultured mammalian cells for enhanced production

The ability of industrially relevant expression systems to produce recombinant protein (rP) has advanced considerably in recent years. However, despite such advances our understanding of the cellular processes that determine/limit rP yield from in vitro cultured mammalian cells remains poor. Thus, our understandings of those cellular processes that constrain or limit rP production (rPP) during bioprocessing are poorly understood and open to conjecture. What is clear is that the constraints are ultimately determined by many different parameters and that cell growth and cell specific productivity alone cannot determine recombinant protein yields. The laboratory therefore has a large number of projects on-going within this area to identify the key mechanisms and genes/proteins that determine or limit recombinant protein yield from in vitro cultured mammalian cells. Some of these projects are in collaboration with Dr Martin Carden, Dr Peter Klappa, Professor Mick Tuite and Dr Tobias von der Haar within the school via funding from the Bioprocessing Research Industry Club (BRIC) whilst others are funded from Research Councils or Industry. We are particularly interested in the modulation of translation and metabolic pathways, the makeup of mRNAs, the role of chaperones and foldases, and the role of the unfolded protein response in recombinant protein production. We are using a combination of genomic/proteomic, molecular biology and protein biochemistry approaches to investigate this large area. We envisage determination of the key processes and mechanisms that determine rPP will allow the modelling of cell performance, allowing the prediction and selection of high producing clones and the development of new approaches for cell engineering to improve recombinant protein yields.




Funding from: BBSRC, EPSRC, Lonza Biologics PLC, MedImmune



back to top

Current members of the Smales group are:

Tanya Knight Laboratory Manager

Dr Jane Povey Postdoctoral Research Associate

Development of predictive tools for the isolation of highly productive cell lines

I joined the Department of Biosciences in 2005 following a Daphne Jackson Fellowship based at Pfizer in Sandwich. My current Post Doc project is involved in improving and developing new methods for screening and selecting recombinant mammalian cell lines. Previously at Kent I worked on a project investigating protein stability in the glassy state. I have a background in protein biochemistry and have previously worked in industry for Welcome (now Murex) Diagnostics, Evans Medical and Cortecs Diagnostics

Dr Catherine Hogwood Postdoctoral Research Associate

Cell line development based on process understanding of host cell protein interactions

My PhD at Kent focussed on investigating the global cellular responses to the chemotherapeutic agent cisplatin with respect to differential p53 expression levels. The three main responses to DNA damage; cell cycle arrest, apoptosis and DNA damage are largely studied independently, however it is hypothesised that these processes come together to form an complex integrated network to ensure the integrity of the genome is protected. An in vitro model cell system and a proteomic approach were applied in which to investigate the hypothesis that considerable crosstalk occurs between the main responses to DNA damage. Through the coupling of 2D-proteomic analysis with mass spectrometry a number of proteins were identified that were up-/down-regulated in response to cisplatin exposure in p53 expressing and p53 knockdown cells in order to further define the role(s) of p53 in the integrated network of responses to DNA damage. This work was undertaken collaboratively between the Lloyd and Smales groups at Kent.

Currently I am working on a project in the Smales group funded through the BRIC initiative (BBSRC, EPSRC and Industrial members) focussed upon the identification/characterization of the major host cell protein (HCPs) contaminants in the cell culture supernatant at harvest of cultured Chinese hamster ovary cells engineered to express therapeutic recombinant proteins. This knowledge should facilitate the development of knowledge based approaches to design more efficient or alternative purification strategies and the rational selection and/or engineering of host cell lines to limit the levels of such problematic HCPs. The project utilises a combination of interrelated approaches to investigate the HCP profile from monoclonal antibody producing cell lines during culture and subsequent downstream processing to determine if these processes and the HCP complement itself can be manipulated to improve, or offer alternatives for, downstream bioprocessing. The direct outcomes of this research and benefits to the bioprocessing industry will be (i) a defined CHO HCP profile for a model system and an understanding of how this changes/accumulates during fermentation and at harvest, (ii) knowledge as to whether the target protein changes the HCP profile and the ease with which these are removed, (iii) an understanding of the HCPs removed by particular chromatographic steps and techniques, (iv) alternative methods of monitoring and measuring HCPs present during bioprocessing, (v) determination of the effects of eliminating specific HCPs on cell phenotype and subsequent downstream bioprocessing, and (vi) the design of novel or alternative processes to remove HCPs via either up- or down-stream approaches.

Dr Angelica Ozanne Postdoctoral Research Associate

Unravelling and engineering the role of trace metals and recombinant therapeutic protein synthesis and heterogeneity from Chinese hamster ovary cells

Dr Barrie Rooney Postdoctoral Research Associate

‘Dipstick’ test tackles fatal sleeping sickness

Barrie has been working on a project to develop a quick and simple diagnosis method, similar to a dipstick pregnancy test, to fight a deadly sleeping sickness. The test to diagnose Human African Trypanosomiasis (HAT) just requires a pin-prick blood sample and will remove the need to take complex equipment into remote areas of sub-Saharan Africa. Existing tests rely on extracts directly from the dangerous parasite, but now the scientists at the School of Biosciences have designed a way to test for the disease more easily and safely, and therefore more cheaply.

The next generation test was developed by Dr Barrie Rooney and Professor Mark Smales, together with School colleagues, working with international medical charity Medecins Sans Frontieres (MSF) in research funded by the Biotechnology and Biological Sciences Research Council (BBSRC) Flexible Interchange Programme (FLIP).

Millions of people are at risk of HAT, which is usually fatal if untreated, with patients falling into a coma before death. Around 5,000 cases are reported each year, with severe social and economic costs, and some areas at risk remain uncovered by surveillance and control efforts. The disease is caused by the parasite Trypanosoma brucei gambiense (T.b. gambiense) and spread by the bite of infected tsetse flies.

Dr Rooney has been involved with MSF mobile HAT screening teams in central African countries for over 10 years. Traditional testing involves a large team in remote areas doing time consuming microscopic work, and painful lumbar punctures, which requires electricity and refrigeration. By combining the latest genome databases and old fashioned fermentation techniques the researchers have come up with a fast, simple way of making robust and reliable tests. The new tests are designed to be heat stable and user-friendly like a dipstick pregnancy test.

The paper “Expression of Trypanosoma brucei gambiense Antigens in Leishmania tarentolae. Potential for Use in Rapid Serodiagnostic Tests (RDTs”) is published in PLOS Neglected Tropical Diseases.

Dr Anne Roobol Honorary Research Associate
Dr Emma Hargreaves Postdoctoral Research Associate
Mr James Budge Postdoctoral Researcher

PHD students

Mrs Stephanie Shellock-Wells
Mrs Shouaa Alrobaish
Mr Andew Martin
Ms Alexandra Binge
Ms Eva Pekle
Ms Ajayi Folasade
Ms Natalie Talbot
Ms Charlotte Godfrey
Mr Theo Mozzanino  
Mr Teddy Jenkins
Mr Linas Tamosatis  
Ms Tulshi Patel
Mr Davide Vito  


back to top

Year 2 BI503 - Cell Biology

  • BI518 - Molecular Biology and Genetics

Final Year BI601 - Skills for Biochemists

  • BI602 - Cellular Communication I
  • BI637 - Forensic DNA Analysis
  • BI631 - Skills for Biomedical Scientists II
  • BI626 - Integrated Endocrinology and Metabolism
back to top
  • Member of BBSRC Bioprocessing Research Industry Club (BRIC) steering panel
  • Executive Editor, Biotechnology Letters
  • Member of Editorial Board, Biotechnology and Applied Biochemistry
  • Member of BioprocessUK strategic steering group
  • Member of ESACT-UK committee
  • Teach on UCL Biochemical Engineering MBI programme
back to top

Enquiries: Phone: +44 (0)1227 823743

School of Biosciences, University of Kent, Canterbury, Kent, CT2 7NJ

Last Updated: 09/01/2017